Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced that Li Yong Ming, Vice President of Zimmer Biomet China and Hong Kong, received the coveted International Alternative Investment Review (IAIR) CEO/MD of the Year Award in Healthcare Solutions for excellence in leadership, inspiration and innovation. IAIR is one of the fastest growing magazines worldwide focusing on global economy and sustainability, and awards its CEO of the Year distinction to outstanding business leaders who demonstrate excellence and proven success in areas such as innovation, organisational growth and personal commitment toward their businesses and people.
Mr. Li is recognised for his entrepreneurial spirit, strategic direction and personal influence in consolidating the Zimmer Biomet businesses in China and Hong Kong, and positioning the company as a leader in the musculoskeletal healthcare field. During his tenure, Mr. Li not only led the successful integration of Zimmer and Biomet following the global merger, but also delivered double-digit growth, sustained organisational commitments and development of a high-performing sales team.
“I am honoured to receive the prestigious IAIR CEO/MD of the Year Award, and humbled to be chosen from among such a stellar group of business leaders and companies,” said Mr. Li. “I share this award with my Asia-Pacific team who played an integral role in modifying the organisational structure and business processes to embrace a more unified, customer-centric business model to improve performance in China and Hong Kong.”
“China’s rapidly ageing population fuels a growing need for innovative and effective solutions to preserve and restore mobility, and Yong Ming has successfully led the strategic expansion of Zimmer Biomet’s Asia Pacific business to capitalise on this significant market growth opportunity while advancing our corporate mission to improve the lives of people with musculoskeletal disorders,” said Sang Yi, President of the Zimmer Biomet Asia-Pacific region.